Thus, CCL22, through its interaction with its receptor CCR4, establishes the local microenvironment to regulate adipose beiging and energy homeostasis, offering therapeutic potential for preventing obesity and related metabolic disorders. The gene discussed is CCR4; the disease is obesity due to melanocortin 4 receptor deficiency.